Order Article Reprints
Journal: Diagnostics, 2024
Volume: 14
Number: 1345
Article:
Clinical Remission Criteria and Serum Levels of Type 2 Inflammation Mediators during 24 Weeks of Treatment with the Anti-IL-5 Drug Mepolizumab in Patients with T2-High Severe Asthma
Authors:
by
Jolita Palacionyte, Andrius Januskevicius, Egle Vasyle, Airidas Rimkunas, Skaidrius Miliauskas and Kestutis Malakauskas
Link:
https://www.mdpi.com/2075-4418/14/13/1345
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.